New blood test could end painful bone biopsies for kidney disease patients

This study is testing whether a blood test that looks at tiny genetic molecules called microRNAs can accurately detect bone problems in people with chronic kidney disease. Currently, doctors rely on a bone biopsy, which is invasive and not practical for most patients. The researchers will compare the blood test results to actual bone tissue samples from 40 participants to see if the test works. If it does, it could make diagnosing and treating bone disease much easier.